Session » (1770–1779) Cytokines & Cell Trafficking Poster
- 10:30AM-12:30PM
-
Abstract Number: 1770
Brepocitinib Inhibits Key Pathogenic Cytokine Signaling in Dermatomyositis Patients
- 10:30AM-12:30PM
-
Abstract Number: 1774
Citrullinated and Malondialdehyde-Acetaldehyde Co-Modified Fibrinogen Activates Macrophages and Induces Pro-Fibrotic shift in Coronary Endothelium Phenotype
- 10:30AM-12:30PM
-
Abstract Number: 1779
Citrullinated and Malondialdehyde-Acetaldehyde Modified Fibrinogen Activates Macrophages and Induces Inflammatory Responses in Coronary Endothelium
- 10:30AM-12:30PM
-
Abstract Number: 1772
Correlation between Soluble Checkpoint Molecules and Disease Activity in Autoimmune Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1777
Granzyme B as a regulator of interferon alpha production in cutaneous lupus erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1771
Interferon- α, Anti-Interferon-Alpha Antibodies and Disease Activity in Systemic Lupus Erythematosus
- 10:30AM-12:30PM
-
Abstract Number: 1776
Preclinical Development of a Novel TL1A-Targeting Antibody with Extended Half-life and Low Immunogenicity Risk for the Treatment of Inflammatory Diseases
- 10:30AM-12:30PM
-
Abstract Number: 1773
Redefining disease activity assessment in IgG4-Related Disease: The role of classical and novel biomarkers
- 10:30AM-12:30PM
-
Abstract Number: 1775
Study Of Type -1 Interferon Gene Signature Markers In Muscle Biopsy Samples Of Patients With IIM
- 10:30AM-12:30PM
-
Abstract Number: 1778
Towards an Earlier and Accurate Diagnosis of Connective Tissue Disease-related Interstitial Lung Disease: TGFB Isoform Genes as Upcoming Biomarkers